Fueling the Fight against HIV/AIDS
It's been more than thirty years since HIV/AIDS first began to emerge in the United States. I'm sure that many of us remember that time clearly, particularly all the fear and uncertainty surrounding the virus.
Since those early days, potent new antiretroviral drugs have been developed that keep HIV under control and have significantly helped improve survival. And while we still have a long way to go in the global fight against AIDS, there has been a promising 21% decrease in new cases since 2000.
Contributing to that decrease is scientific research, including an especially influential body of work by investigators at Weill Cornell Medicine. According to the Thomson Reuters Web of Science database, Scripps Research Institute and Weill Cornell are the two most prolific institutions producing "Hot Papers" in the field of HIV/AIDS over the past two years.
Four Weill Cornell researchers in the department of microbiology and immunology also made the list of top 10 authors of "Hot Papers": John Moore, Albert Cupo, Per Johan Klasse, and Rogier Sanders. In collaboration with researchers at Scripps, this team is responsible for groundbreaking work in determining the structure of the HIV-1 envelope trimer, an accomplishment that has great potential for HIV/AIDS vaccine development.
Other researchers at Weill Cornell Medicine, including Scott Blanchard, are building on that team's work and examining the motion of proteins on the surface of HIV using new technology. And of course, clinical care and research in HIV/AIDS has been offered for many years through the Center for Special Studies in Chelsea and GHESKIO in Haiti.
The collective efforts of many investigators have propelled Weill Cornell Medicine into the very top ranks of institutions that do AIDS research. Together, they're giving us the tools we need to create a world without AIDS.
Posted February 9, 2016 11:38 AM | Permalink to this post